---

Germfree offers a range of turnkey, mobile and modular cleanrooms and biocontainment facilities to service regulated market segments in Biopharma, Compounding Pharmacy, and Biocontainment. The Company’s product offering is suited for the market of cell and gene therapy manufacturing. Each solution integrates the Company’s technologies, equipment, and innovative designs and is manufactured to meet industry standards for manufacturing processes and/or biocontainment. Germfree is headquartered and operates a 175,000 sq. ft. production plant in Ormond Beach, Florida. EW acquired Germfree in October 2022 and plans to use its experience and market knowledge to increase manufacturing footprint and expand customer base and offerings.

• Ormond Beach, FL


• Contact:
  Evis Hursever
  Brooks Andrews
  

Related News

• Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
• Germfree Announces the Appointment of Four Independent Board Members
• EW Healthcare Partners Acquires Germfree Laboratories, Inc.